Quantum量子訊息有限公司
← 最新全球產業報告

Cardiac Implants Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-02-09 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 48,862 Mn
2033 年預估規模
USD 83,490 Mn
年複合成長率 CAGR
8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-02-09頁數 152報告編號 CMI1176

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Cardiac Implants Market, By Device Type (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve, and Others), By Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

An implantable cardiac devices is used to regulate and detect irregular heartbeat. The implantable cardiac device includes biventricular pacemakers, pacemakers, implantable cardioverter defibrillator (ICD), and cardiac loop recorders. Biomaterial used in manufacturing cardiac implants are biocreamics, polymers, composite materials, metals and their alloys. The implantable cardioverter-defibrillator is categorized into two types namely traditional ICD and subcutaneous ICD (S-ICD). There are eight types of U.S. Food and Drug Administration (U.S. FDA) approved devices that treat the heart disorders such as automated external defibrillators (AEDs), cardiac ablation catheters, cardiovascular angioplasty devices, cardiac pacemakers, implantable cardioverter defibrillators (ICDs), prosthetic (artificial) heart valves, stents, ventricular assist devices (VADs). Cardiac implantable electric device such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices are extensively used for cardiac disorders. Furthermore, there are two types of pacemakers used single chamber pacemaker and dual-chamber pacemaker. Market Dynamics Key players operating in cardiac implants market are launching new products based on advanced technologies, which is contributing to growth of the cardiac implants market. For instance, in April 2022, MicroPort CRM, a China-based cardiac rhythm management announced that it received MRI-conditional CE mark approval from the European Union for its Ulys and Edis ICDs. These new ICDs are high-voltage devices incorporated with advanced technology which allows low current consumption, resulting in long lifespan of the devices. The increasing efforts and innovative technologies are seen to emerge new strategy for driving the market. Hence, the launch of the advanced cardiac implants is expected to drive the market growth over the forecast period. Key features of the study • This report provides an in-depth analysis of the global cardiac implants market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global cardiac implants market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies • Key companies covered as a part of this study include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, OSYPKA MEDICAL, Pacetronix.com, Vitatron, Terumo Corporation, Cordis, MicroPort Scientific Corporation. • Global cardiac implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have an ease in decision-making through various strategy matrices used in analysing the global cardiac implants market Market Segmentation • Device Type Insights (Revenue, USD Mn, 2026 - 2033) o Pacemaker Devices o Cardiac Resynchronization Therapy Devices o Implantable Hemodynamic Monitoring Devices o Implanted Heart Rhythm Monitors o Coronary Stents o Implantable Cardioverter Defibrillator o Heart Valve o Others • Application Insights (Revenue, USD Mn, 2026 - 2033) o Arrhythmias o Myocardial Ischemia o Acute Myocardial Infraction o Congestive Heart Failure o Others • End User Insights (Revenue, USD Mn, 2026 - 2033) o Hospitals o Specialty Clinics o Others • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Abbott Laboratories o Braun Melsungen AG o Boston Scientific Corporation o Edwards Lifesciences Corporation o Meril Life Sciences Pvt. Ltd. o Lepu Medical Technology (Beijing) Co., Ltd. o BIOTRONIK SE & Co. KG o OSYPKA MEDICAL o Pacetronix.com o Vitatron o Terumo Corporation o Cordis o MicroPort Scientific Corporation
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Device Type  Market Snapshot, By Application  Market Snapshot, By End User  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Opportunity o Impact Analysis o Key Developments o Regulatory Scenario o Market Trends o Key Developments o Technology Advancements o Substitutes/Alternatives o Epidemiology o Electronic Components of Cardiac Implants o Overview of Sensors used in Cardiac Implants o Risk of Infection o Partnerships and Acquisitions o Regulatory Scenario o PORTER’S Five Forces o PEST Analysis o Brand and Distributor Analysis o Pricing Analysis o Product Recalls o Number of Hospitals and Ambulatory Surgery Centers, by Country o Number of Procedures/Surgeries by Country 4. Global Cardiac Implants Market, By Device Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Pacemaker Devices  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Cardiac Resynchronization Therapy Devices  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Implantable Hemodynamic Monitoring Devices  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Implanted Heart Rhythm Monitors  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Coronary Stents  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Implantable Cardioverter Defibrillator  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Heart Valve  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 5. Global Cardiac Implants Market, By Application, 2026-2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Arrhythmias  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Myocardial Ischemia  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Acute Myocardial Infraction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Congestive Heart Failure  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Cardiac Implants Market, By End User, 2026-2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Hospitals  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Specialty Clinics  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Cardiac Implants Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o U.K. o Germany o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Device Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Application, 2026-2033, (USD Mn)  Market Size and Forecast, By End User, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Heat Map Analysis o Company Profile  Abbott Laboratories o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  B. Braun Melsungen AG o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Boston Scientific Corporation o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Edwards Lifesciences Corporation o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Meril Life Sciences Pvt. Ltd o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Lepu Medical Technology (Beijing) Co., Ltd. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  BIOTRONIK SE & Co. KG o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  OSYPKA MEDICAL o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Pacetronix.com o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Vitatron o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Terumo Corporation o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Cordis o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  MicroPort Scientific Corporation o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies o Analyst Views 9. Section o Research Methodology o About us

提及公司

Abbott LaboratoriesBraun Melsungen AGBoston Scientific CorporationEdwards Lifesciences CorporationMeril Life Sciences Pvt. Ltd.Lepu Medical Technology (Beijing) Co., Ltd.BIOTRONIK SE & Co. KGOSYPKA MEDICALPacetronix.comVitatronTerumo CorporationCordisMicroPort Scientific Corporation

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們